Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,144.2
-16.5 (-0.52%)

 

  • STI Straits Times Index
    3,144.2
    -16.5 (-0.52%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,566.2
    -7.9 (-0.50%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,566.7
    -219.5 (-0.82%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,941.6
    -12.8 (-0.43%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,625.4
    76.5 (0.34%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,237.4
    11.9 (0.19%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,080.6
    -8.2 (-0.39%)
    Index delayed 20 minutes
  • XAO XAO
    6,778.2
    -0.4 (-0.01%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 631.0M
  • Value: 754.4M
  • Rise: 119
  • Fall: 170
  • Unch: 542

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
SunMoonFood^0.067-0.002
Rex Intl0.096+0.001
Sembcorp Marine1.390+0.040
Golden Agri-Res0.210-
Mapletree Log Tr1.680+0.020
TEE Intl0.047+0.003
Capital World0.010-0.002
Singapore-eDev0.050-
SingTel3.240-0.020
AEM1.360+0.030

World Indices

World Indices
Name Last Change
Nasdaq 8,104.3 -58.7
HSI 26,566.7 -219.5
HSCEI 10,451.7 -75.2
Jakarta 6,234.4 +8.9
Nikkei 225 22,625.4 +76.5
SSE Comp 2,941.6 -12.8
Shanghai A 3,081.8 -13.4
Shanghai B 264.3 -1.3
PSE Comp 0.0
KOSPI 2,080.6 -8.2

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

EMERGENT BIOSOLUTIONS INC EMERGENT BIOSOLUTIONS
Updated on 22 Oct 2019 (End of trading day)
Last (USD): 54.270 Change: +2.200 High: 54.460 Remarks: -
Change (%): +4.23 Low: 51.970
Open 52.190 Yesterday's Close 52.07
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 317,527 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a 1.21512 Trailing EPS (USD) e -0.34797 NAV (USD) b 19.1647
PE a 44.662 Trailing PE f - Price / NAV b 2.8318
Dividend (USD) d - Cash In Hand (USD) g 3.4419 Issued & Paid-up Shares c 51,600,000
Dividend Yield (%) d - Price / Cash In Hand g 15.767 Treasury Shares h 1,200,000
Beta - 75 Daysi 0.771 R-Squared - 75 Days(%)i 3.97 Market Cap (M) 2,800.332
Beta - 500 Daysi 0.943 R-Squared - 500 Days (%)i 10.40 Enterprise Value (M) 3,479.732
Piotroski F Score 3 Exchange Code EBS Par Value ( $ ) n.a.
52 Weeks Volatility (%) 48.20 Free Float (%) 85.4
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 05 Aug 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 25 Feb 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference EMERGENT BIOSOLUTIONS INC NYSE 2,800.332 44.662 - 2.8318 -
Industry Biotechnology NYSE 4,554.799 15344.635 41.175 4.4094 0.694
Local Peer AGILENT TECHNOLOGIES INC NYSE 23,114.165 73.146 21.562 4.8692 0.820
Local Peer MYOVANT SCIENCES LTD NYSE 466.936 - - 5.8684 -
Local Peer KADMON HLDGS INC NYSE 388.905 - - 3.9022 -
Local Peer ARCUS BIOSCIENCES INC NYSE 404.848 - - 2.0588 -
Local Peer ENZO BIOCHEM INC NYSE 153.609 61.712 61.715 1.7856 -
Global Peer AMGEN INC NASDAQ 122,836.756 14.634 15.436 11.3801 2.706
Global Peer GILEAD SCIENCES INC NASDAQ 83,408.397 15.290 14.006 3.6880 3.504
Global Peer CSL ASX 113,805.144 42.418 42.418 15.2082 1.058
Global Peer AMGEN-T HKEx 599,701.000 9.116 9.612 7.1115 4.345
Global Peer CELGENE CORP NASDAQ 74,205.183 18.340 14.078 7.3829 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 49,109.107 23.425 22.171 9.6863 -
Global Peer ILLUMINA INC NASDAQ 45,430.350 55.000 48.433 10.4871 -
Global Peer BIOGEN INC NASDAQ 51,990.076 11.734 9.820 4.0138 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 33,112.267 13.546 16.002 3.3941 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 22,261.257 286.870 16.693 2.1903 -
Other Global Peers SINO BIOPHARM (HKEx), SEATTLE GENETICS INC (NASDAQ), INCYTE CORPORATION (NASDAQ), WUXI BIO (HKEx), BIOMARIN PHARMACEUTICAL (NASDAQ), EXACT SCIENCES CORP (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BEIGENE (HKEx), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), MODERNA INC (NASDAQ), EXELIXIS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), 3SBIO (HKEx), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), Lonza (SGX), REPLIGEN CORP (NASDAQ), GENSCRIPT BIO (HKEx), BLUEPRINT MEDICINES CORP (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), FIBROGEN INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), IMMUNOMEDICS INC (NASDAQ), NATERA INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), GENOMIC HEALTH INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), 10X GENOMICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), XENCOR INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), ALDER BIOPHARMACEUTICALS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), OPKO HEALTH INC (NASDAQ), FRONTAGE (HKEx), VERACYTE INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), POLYNOVO LIMITED (ASX), FATE THERAPEUTICS (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), VIELA BIO INC (NASDAQ), VIVA BIOTECH (HKEx), EDITAS MEDICINE INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), HAOHAI BIOTEC (HKEx), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), AVITA MEDICAL LTD (ASX), INTREXON CORP (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), OMEROS CORP (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), VANDA PHARMACE INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), NEXTCURE INC (NASDAQ), MESOBLAST LTD (ASX), HOMOLOGY MEDICINES INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), CORTEXYME INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), MACROGENICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), TRANSLATE BIO INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), RETROPHIN INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), SYNTHORX INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ASCLETIS-B (HKEx), PROGENICS PHARMACEUTICALS INC (NASDAQ), CKLIFE SCIENCES (HKEx), MERIDIAN BIOSCIENCE INC COM (NASDAQ), ESSEX BIO-TECH (HKEx), FREQUENCY THERAPEUTICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), IMMUNOGEN INC (NASDAQ), XBIOTECH INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), DERMIRA INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), PERSONALIS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), MEDICINOVA INC (NASDAQ), AGENUS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), NEXT SCIENCE LTD (ASX), CYMABAY THERAPEUTICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), LEE'S PHARM (HKEx), PRECISION BIOSCIENCES INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), ARDELYX INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), RECRO PHARMA INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), TELIX PHARMACEUTIC (ASX), GERON CORP (NASDAQ), PDL BIOPHARMA INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), RESTORBIO INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), COMPUGEN (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), MANNKIND CORPORATION (NASDAQ), SERES THERAPEUTICS (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), DPHARMA (Bursa), GLYCOMIMETICS INC (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), SORRENTO THERAPEUTICS INC (NASDAQ), PFENEX INC (NYSE American), CHIASMA INC (NASDAQ), KAMADA (NASDAQ), ATHERSYS INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), AFFIMED N V (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), BICYCLE THERAPEUTICS LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), BBI LIFE SCI (HKEx), CUE BIOPHARMA INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), XOMA CORP (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), UNI-BIO GROUP (HKEx), AVEO PHARMACEUTICALS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), NANOVIRICIDES INC (NYSE American), CALITHERA BIOSCIENCES INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), IMV INC (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), NABRIVA THERAPEUTICS PLC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), AVALON GLOBOCARE CORP (NASDAQ), AXCELLA HEALTH INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), SESEN BIO INC (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), JOUNCE THERAPEUTICS INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), PHYLOGICA LIMITED (ASX), NANTKWEST INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), NOVAVAX INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), VBI VACCINES INC CDA (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), FORTRESS BIOTECH INC (NASDAQ), CHIMERIX INC (NASDAQ), TREVENA INC (NASDAQ), VERASTEM INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), VACCINEX INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), IMMUTEP LTD (ASX), ARAVIVE INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), IMMUTEP LTD SPON ADR EACH REP 100 ORD SHS (NASDAQ), CEL-SCI CORP (NYSE American), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), SYNLOGIC INC (NASDAQ), CURIS INC (NASDAQ), OTONOMY INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), CATALYST BIOSCIENCES INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), PORT (SET), EQUILLIUM INC (NASDAQ), INFLARX N V (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), ORGENESIS INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), INMUNE BIO INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), VERMILLION INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), CT ENTERPRISE (HKEx), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), IMUGENE LIMITED (ASX), ORTHOCELL LIMITED (ASX), IBIO INC (NYSE American), VASCULAR BIOGENICS LTD (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 2 ORD SHS (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), EVOGENE LTD (NASDAQ), IVERIC BIO INC (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), BIONOMICS LTD (ASX), SURFACE ONCOLOGY INC (NASDAQ), MEMPHASYS LTD (ASX), BELLICUM PHARMACEUTICALS (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), SAVARA INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), REGENT PACIFIC (HKEx), INDIA GLOBALIZATION CAPITAL INC (NYSE American), BIOTRON (ASX), ACTINOGEN MEDICAL LTD (ASX), FIBROCELL SCIENCE INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), BIOCARDIA INC (NASDAQ), RHINOMED LIMITED (ASX), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), ZAFGEN INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), CONTRAFECT CORP (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), BIOSINO BIO-TEC (HKEx), EXTRAWELL PHAR (HKEx), SENESTECH INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), ORAGENICS INC (NYSE American), AETERNA ZENTARIS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), KAZIA THERAPEUTICS LIMITED (ASX), INVEX THERAPEUTICS LTD NPV (ASX), OCUGEN INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), SOLIGENIX INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), PROTEOMICS INTL LABORATORIES LTD (ASX), BIOCEPT INC (NASDAQ), ISORAY INC (NYSE American), SOPHIRIS BIO INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), GENETIC TECHNOLOGIES (ASX), PATRYS LIMITED (ASX), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), TOCAGEN INC (NASDAQ), IMMURON LIMITED (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), CELLECTAR BIOSCIENCES INC (NASDAQ), PRECIPIO INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), REGENEUS LTD (ASX), DARE BIOSCIENCE INC (NASDAQ), ADALTA LTD (ASX), Suntar Eco-City^ (SGX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), ATYR PHARMA INC (NASDAQ), VAXART INC (NASDAQ), ANTEO DIAGNOSTICS LIMITED (ASX), PULMATRIX INCORPORATED (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), AUSTRALIAN PRIMARY HEMP LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), ACHIEVE LIFE SCIENCE INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), CELLMID LIMITED (ASX), BIONANO GENOMICS INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), BENITEC BIOPHARMA LTD (ASX), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), BENITEC BIOPHARMA LTD SPON ADR EA REPR 20 ORD (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), ONCONOVA THERAPEUTICS INC (NASDAQ), HAO WEN HLDGS (HKEx), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), MEGASUN (Bursa), ADVAXIS INC (NASDAQ), BIOXYNE LIMITED (ASX), MEDIBIO LIMITED (ASX), LIVING CELL TECHNOLOGIES (ASX), ARCA BIOPHARMA INC (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), REXAHN PHARMACEUTICALS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), MGRC (Bursa), ANATARA LIFESCIENCES LTD (ASX), AIM IMMUNOTECH INC (NYSE American), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), TROVAGENE INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), TBG DIAGNOSTICS LTD (ASX), DIFFUSION PHARMACEUTICALS INC (NASDAQ), OPGEN INC (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), PHIO PHARMACEUTICALS CORP (NASDAQ), QT Vascular (SGX), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), CCP TECHNOLOGIES LTD (ASX), AURIS MEDICAL HOLDING LTD (NASDAQ), NANOLLOSE LTD (ASX), NOVITA HEALTHCARE LTD (ASX), SPHERIX INC (NASDAQ), NEURALSTEM INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), BPH ENERGY LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.480
+0.89 %
10 Days -+2.140
+4.11 %
20 Days -+3.320
+6.52 %
Medium Term Return 3 Months -+10.040
+22.70 %
6 Months -+0.690
+1.29 %
1 Year --4.230
-7.23 %
Long Term Return 2 Years -+14.180
+35.37 %
3 Years -+26.500
+95.43 %
5 Years -+33.744
+164.40 %
Annualised Return Annualised --
+21.46 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 39.110 - 73.890 Change From 1 Year Low +15.160 % Change From 1 Year Low (%) +38.76
Change From 1 Year High -19.620 % Change From 1 Year High (%) -26.55
2 Years Range 36.380 - 73.890 Change From 2 Years Low +17.890 % Change From 2 Years Low (%) +49.18
Change From 2 Years High -19.620 % Change From 2 Years High (%) -26.55
5 Years Range 20.207 - 73.890 Change From 5 Years Low +34.063 % Change From 5 Years Low (%) +168.57
Change From 5 Years High -19.620 % Change From 5 Years High (%) -26.55
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers specialty products for civilian and military populations that address accidental, intentional and naturally occurring public health threats. Its business units include Vaccines and Anti-Infectives; Antibody Therapeutics; Devices; and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri in May 1998 and is headquartered in Gaithersburg, MD.

Historical Price Data

Date Open High Low Close Volume VWAP
22 Oct 2019 52.190 54.460 51.970 54.270 317,527 -
21 Oct 2019 56.050 56.050 51.975 52.070 411,038 -
18 Oct 2019 53.990 55.175 53.990 54.910 274,494 -
17 Oct 2019 54.050 54.880 53.680 54.170 217,436 -
16 Oct 2019 53.990 54.900 53.390 53.790 369,352 -
15 Oct 2019 52.620 54.320 52.010 54.230 275,738 -
14 Oct 2019 52.290 52.750 51.790 52.470 116,486 -
11 Oct 2019 53.000 53.420 52.340 52.580 209,464 -
10 Oct 2019 52.420 53.025 51.860 52.500 194,054 -
09 Oct 2019 52.270 52.610 50.900 52.130 139,583 -
08 Oct 2019 53.610 53.610 51.660 51.780 171,477 -
07 Oct 2019 53.720 54.520 53.400 54.070 333,974 -
04 Oct 2019 54.030 54.800 52.438 54.140 294,274 -
03 Oct 2019 52.760 54.000 52.295 53.750 349,527 -
02 Oct 2019 51.920 53.270 51.620 52.800 387,812 -
01 Oct 2019 52.170 53.440 51.800 52.360 390,898 -
30 Sep 2019 51.470 52.760 51.000 52.280 319,714 -
27 Sep 2019 51.020 52.010 50.530 51.020 305,001 -
26 Sep 2019 51.040 51.410 49.920 50.730 296,012 -
25 Sep 2019 51.480 52.240 50.760 50.950 341,869 -
24 Sep 2019 52.330 52.525 51.540 51.610 300,875 -
23 Sep 2019 51.070 52.380 50.800 51.880 506,018 -
Summary
Current 2 Weeks
(09 Oct 2019 to 22 Oct 2019)
52.270 56.050 50.900 54.270 2,525,172 -
Previous 2 Weeks
(25 Sep 2019 to 08 Oct 2019)
51.480 56.050 50.760 51.780 3,190,558 -
4 Weeks from
(27 Aug 2019 to 24 Sep 2019)
41.250 56.050 39.110 51.610 14,644,039 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.